Myeloma proteins as tumor-specific transplantation antigens - Wikidata - awgldk - TriplyDB

Myeloma proteins as tumor-specific transplantation antigens

Myeloma proteins as tumor-specific transplantation antigens

http://www.wikidata.org/entity/Q34709927

about

Immunogenic targets for specific immunotherapy in multiple myeloma Immunotherapy strategies for multiple myeloma: the present and the future A novel mouse model for multiple myeloma (MOPC315.BM) that allows noninvasive spatiotemporal detection of osteolytic disease Autologous lymphoma vaccines induce human T cell responses against multiple, unique epitopes.Vaccines in oncology: background and clinical potential.Cell-bound myeloma proteins on the surface of myeloma cells: potential targets for the immune system Cell-free translation of immunoglobulin messenger RNA from MOPC-315 plasmacytoma and MOPC-315 NR, a variant synthesizing only light chain Dendritic cells purified from myeloma are primed with tumor-specific antigen (idiotype) and activate CD4+ T cells.Localization of idiotypic antigenic determinants in the Fv region of murine myeloma protein MOPC-315.Vaccination with patient-specific tumor-derived antigen in first remission improves disease-free survival in follicular lymphoma Dendritic cell-based immunotherapy for the treatment of hematological malignancies.Towards an off-the-shelf vaccine therapy targeting shared B-cell tumor idiotypes.Naive idiotype-specific CD4+ T cells and immunosurveillance of B-cell tumors.Dendritic cell-based immunotherapy in multiple myeloma.Th1/Th2 cells in patients with multiple myeloma.Idiotype vaccines in the treatment of B-cell non-Hodgkin's lymphoma.Rous-Whipple Award lecture. The biology and pathology of lymphocyte Fc receptors Therapeutic idiotype vaccines in B lymphoproliferative diseases.Effect of solubilized membrane antigens and tumour bearer serum on tumour growth in syngeneic hosts.Induction of resistance or enhancement to a transplantable murine plasmacytoma by transfer of non-immune leucocytes.A vaccine directed to B cells and produced by cell-free protein synthesis generates potent antilymphoma immunity DNA vaccines, electroporation and their applications in cancer treatment Protective and cellular immune responses to idiotypic determinants on cells from a spontaneous lymphoma of NZB-NZW F1 mice A small hypervariable segment in the variable domain of an immunoglobulin light chain stimulates formation of anti-idiotypic suppressor T cells.Neoantigen and tumor antigen-specific immunity transferred from immunized donors is detectable early after allogeneic transplantation in myeloma patients.Control of immunoglobulin secretion in the murine plasmacytoma line MOPC 315.Immunoregulation of murine myeloma in vitro. II. Suppression of MOPC-315 immunoglobulin secretion and synthesis by idiotype-specific suppressor T cells Suppression of in vivo tumor formation induced by simian virus 40-transformed cells in mice receiving antiidiotypic antibodies.Syngeneic antiidiotypic immune responses to a B cell lymphoma. Comparison between heavy chain hypervariable region peptides and intact Ig as immunogens.Presence of clonal T cell populations in chronic B lymphocytic leukemia and smoldering myeloma.Anti-idiotype sera raised against surface immunoglobulin of human neoplastic lymphocytes Components of immune function studied with lymphoid tumors.Epstein-Barr virus-encoded dUTPase enhances proinflammatory cytokine production by macrophages in contact with endothelial cells: evidence for depression-induced atherosclerotic risk.Trial watch: Peptide vaccines in cancer therapy Therapeutic lymphoma vaccines: importance of T-cell immunity.BiovaxID: a personalized therapeutic cancer vaccine for non-Hodgkin's lymphoma.Mechanisms of action of immune tolerance induction against factor VIII in patients with congenital haemophilia A and factor VIII inhibitors.Therapeutic vaccine for lymphoma.Development of orally active inhibitors of protein and cellular fucosylation BiovaxID idiotype vaccination: active immunotherapy for follicular lymphoma.

P2860

Q26859007-22D04C2A-27EA-4A10-922A-628A3129798D Q27021939-61D58D7E-622C-4D74-83BE-13FB87EC59F9 Q27329429-95BA2A07-6244-4FA8-8353-DDADC57DF0B7 Q33785039-EFDBC730-B9B0-45D3-AC64-7C039FFEE838 Q34439914-48C6DD8A-DFF3-47AE-9E2D-F6020F9F5493 Q34722592-8E9C8BE4-108C-474F-99EE-FA75276A44C1 Q35067105-EF58EF79-B1E6-46BA-8184-7486CECC388E Q35079386-0C90930B-351F-4511-8D0D-995B31DCC5B1 Q35104724-37AAE438-E5E1-457D-9E40-3ACB5DE5B444 Q35114545-319004A1-F772-4D72-AC3F-C4A83871266C Q35127001-0868138F-ABF3-47D4-8E21-8D8463B9EE48 Q35144751-661CF8B1-8EC1-4B58-B8C9-B349D54A9813 Q35525622-BA89F85C-F0D8-4747-871E-CCA8906D9026 Q35665926-91619DA9-6B3C-435D-A3E7-3B2523AACB05 Q35668682-8C850076-240A-48DE-AF40-5055993C22A3 Q35740264-AB31BEDF-BE4E-4177-AF85-2F70DBA7104E Q35765095-83FAB53D-C356-42C2-90BD-8BA9F7C0AAAC Q35790890-3C14EDC9-C75B-4718-A0B4-6C95F37DC816 Q36041211-6735047D-7E7A-457B-B91E-FE0A5035F989 Q36068785-9DC5C013-901D-4C6D-A428-B8342A74F7BC Q36221727-D8B69A91-B46A-4BE9-A3E7-10EEF4C5D41B Q36256459-18CCB811-9DCF-4EC7-BAB3-0840EE192EE6 Q36273765-7C396803-BC16-4E7D-A528-4C7AE8F25982 Q36311069-30B4C5D5-631A-4120-ADA9-DFAAE90B404A Q36312922-8777FC70-EE89-42CE-A9DC-FD20D24D400E Q36341687-8B330A06-1964-45DF-93E8-74AEB2444908 Q36346219-A94764DA-9283-4D94-B001-0CF0B109570F Q36350167-1F775F44-A821-4710-A2E7-9E2D77A4F8BD Q36350351-26077462-4A71-4C11-96DC-EEB8F55BD24A Q36350676-50F4F5B9-FF16-46D3-A6DE-AADDB56318E3 Q36359921-11000F46-B36D-422C-B548-7DCBF52C08F8 Q36448825-D4062CFE-6DA8-4C2C-BD7C-8D6C8729A6E5 Q36464484-A8F1DBE3-23A3-4DAB-9F6E-AEA2BDF0D988 Q36476100-A62B3F80-1B67-4D8D-8F93-203DEC4BAAE6 Q36530231-E94BBC25-A704-498E-991B-5735D8887E47 Q36675461-D13058F7-8BC2-4B0A-AAD6-8E84767CC6F1 Q36707550-496CAB74-3822-4B5E-9755-DF6E271C6CD1 Q36746586-4D462571-C77D-4987-BCF4-B678A908DE16 Q36747458-9A454B10-EDA0-424D-9679-0E5D256C2B78 Q36837124-5190E051-6FCB-4ECC-B41D-049028472246

P2860

Myeloma proteins as tumor-specific transplantation antigens

http://www.wikidata.org/entity/Q34709927

description

1972 nî lūn-bûn

@nan

1972 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

1972 թվականի հունիսին հրատարակված գիտական հոդված

@hy

1972年の論文

@ja

1972年論文

@yue

1972年論文

@zh-hant

1972年論文

@zh-hk

1972年論文

@zh-mo

1972年論文

@zh-tw

1972年论文

@wuu

name

Myeloma proteins as tumor-specific transplantation antigens

@ast

Myeloma proteins as tumor-specific transplantation antigens

@en

Myeloma proteins as tumor-specific transplantation antigens

@nl

type

label

Myeloma proteins as tumor-specific transplantation antigens

@ast

Myeloma proteins as tumor-specific transplantation antigens

@en

Myeloma proteins as tumor-specific transplantation antigens

@nl

prefLabel

Myeloma proteins as tumor-specific transplantation antigens

@ast

Myeloma proteins as tumor-specific transplantation antigens

@en

Myeloma proteins as tumor-specific transplantation antigens

@nl

P1433

Q34709927-6B2EB2DA-64AF-4810-B9C3-52D9960EAA27

P1476

Q34709927-BB5ABA5E-D0F1-477B-B6F6-2FE03F953BC1

P2093

Q34709927-26479187-4E30-42C1-9677-72C1AA6DBD76

Q34709927-6A07DCC5-F7B9-4C04-94E1-06BDBF46E494

Q34709927-6F6A643E-4033-40B5-9B98-8F2C6D292850

Q34709927-B7251D2A-A144-4783-9CF5-B0094AAD2DCA

Q34709927-EDB624E8-891A-4977-BE60-4C53B264A133

P2860

Q34709927-26900F12-35F9-45C8-91A4-4C3E1C740EFF

Q34709927-452015FE-AC4E-4C90-963E-3ED972242F94

Q34709927-516C6DA1-C086-4049-8935-547DCF8B1125

Q34709927-5D023FC3-7A3B-4356-B438-C3596D0FD654

Q34709927-97D8A083-D3EE-4C6B-9953-2BE15A9E73E8

Q34709927-C59A091A-0B2B-4E90-9443-857B0B59FD83

Q34709927-F73553B6-EBFB-4BC7-89E3-81EC2B91B6A6

P304

Q34709927-2F7E1CE6-0216-4007-8E1B-B25972483137

P31

Q34709927-FC82D6D7-1C9C-4BA1-B74B-2FB15F175FDA

P356

Q34709927-EEAE90E3-E5AD-4FA1-A5C4-43E663887F35

P407

Q34709927-EB8B54D3-6C0E-43E1-9404-32C585840BAD

P433

Q34709927-5D80ED00-E02E-4023-A0B3-3ADBF21A242C

P478

Q34709927-F045468D-72B5-4A15-9C45-18AC84ADB9A7

P577

Q34709927-803BB315-5F6C-43CE-B551-9079207C1C81

P5875

Q34709927-45A0D3AE-7C15-469D-8360-CA5AFD6E891D

P698

Q34709927-9B1CF0A4-1837-4D03-8A07-5B661730605F

P932

Q34709927-39AD75BA-7B68-44C7-A11A-72AB121768EB

P356

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Myeloma proteins as tumor-specific transplantation antigens

@en

P2093

Eisen HN

http://www.w3.org/2001/XMLSchema#string

Graff RJ

http://www.w3.org/2001/XMLSchema#string

Lynch RG

http://www.w3.org/2001/XMLSchema#string

Simms ES

http://www.w3.org/2001/XMLSchema#string

Sirisinha S

http://www.w3.org/2001/XMLSchema#string

P2860

Immunochemical quantitation of antigens by single radial immunodiffusion

Quantitative investigations of idiotypic antibodies. IV. Inhibition by specific haptens of the reaction of anti-hapten antibody with its anti-idiotypic antibody.

Amino acid sequence of the light chain from a mouse myeloma protein with anti-hapten activity: evidence for a third type of light chain.

Autoimmune-like antibodies to the ligand-binding sites of myeloma proteins.

Rate of somatic mutation in immunoglobulin production by mouse myeloma cells.

Immunology and malignant disease.

Genetics of immunoglobulins in the mouse.

P304

1540-1544

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.69.6.1540

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

69

http://www.w3.org/2001/XMLSchema#string

P577

1972-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

19051498

http://www.w3.org/2001/XMLSchema#string

P698

4113870

http://www.w3.org/2001/XMLSchema#string

P932

426744

http://www.w3.org/2001/XMLSchema#string